PDK4 and ovarian cancer: Numerous reports have evidenced that PDK4 is aberrantly expressed in human malignancies, such as gastric cancer (Zhang, et al. 2022), liver cancer (Si et al. 2023), ovarian cancer (Wang et al. 2019) and so on.